 |
David Braff, M.D.
Education/Training
Institution and Location
|
Degree, if applicable
|
Year(s)
|
Field of Study |
Union College, Schenectady, NY
|
BS
|
1966
|
Biology, Psychology |
School of Medicine, Univ. Of Pennsylvania, Philadelphia
|
MD
|
1970
|
Medicine |
Children’s Hospital, Univ. Of California, San Francisco
|
- |
1971
|
Intern |
Dept. of Psychiatry, Yale University School of Medicine,
CT
|
- |
1971-1972
|
Resident I |
Dept. of Psychiatry, UCSF School of Medicine, and
|
- |
1972-1974
|
Resident II-III |
Langley Porter Neuropsychiatric Institute, San Francisco,
CA
|
- |
1972-1974
|
Chief Resident |
|
A. Positions and Honors
| 1974 – 1976 |
Assistant Clinical Professor and Assistant Chief
of Clinical Research Ward, Langley Porter Institute and the Department
of Psychiatry, School of Medicine, University of California,
San Francisco |
| 1976 – 1982 |
Assistant Professor, Department of Psychiatry, School of Medicine,
University of California, San Diego |
| 1976 – 1995 |
Director, Inpatient Psychiatry Service, University of California
Medical Center, San Diego |
| 1982 – 1988 |
Associate Professor, Department of Psychiatry, School of Medicine,
University of California, San Diego |
| 1988 – 1996 |
Director, Psychiatry Services, University of California Medical
Center, San Diego |
| 1988 |
Editorial Boards -- Archives of General Psychiatry (1997-Pres),
Journal of Psychiatric Research (1993-Pres), Schizophrenia Research
(1989-Pres), Schizophrenia Bulletin (Associate Editor, 1988-1992;
Editorial Board, 1993-Pres), Biological Psychiatry (1997-Pres) |
| 1989 |
Principal Investigator, NIH/NIMH MERIT Research Award |
| 1996 |
1998 President Elect & President, Society of Biological
Psychiatry |
| 1997 |
Acting Editor for Archives of General Psychiatry and Biological
Psychiatry (selected articles) |
| 1997 |
Director, UCSD Schizophrenia Program |
| 1997 |
President, UCSD Faculty Association |
| 1998 |
Executive Secretary, Society of Biological Psychiatry |
| 1998 |
Co-Chair, Executive Committee, VISN 22, Veterans Administration
Mental Illness Research, Education, and Clinical Center (MIRECC),
and San Diego Co-Principal Investigator |
| 2000 – 2002 |
Councilor, American College of Neuropsychopharmacology |
| 1988 |
Professor, Department of Psychiatry, School of Medicine, University
of California, San Diego |
B. Selected peer-reviewed publications (in chronological order).
*** Selected
from over 200 published articles
Braff, D.L.: Connecting the "dots" of brain dysfunction in schizophrenia:
what does the picture look like? Archives of General Psychiatry. 56(9):791-3,
1999.
Davis KL, Braff DL, Weinberger DR: Protecting research subjects
and psychiatric research: we can do both. Biological Psychology, 46(6):727-728,1999
Light
GA & Braff DL.: Measuring P50 suppression and prepulse
inhibition in a single recording session. American Journal of Psychiatry.158(12):2066-8,
2001
Cadenhead, K.S. & Braff, D.L.: Endophenotyping schizotypy: A prelude
to genetic studies within the schizophrenia spectrum. Schizophrenia Research,
54:47-57, 2002.
Braff, D.L. & Freedman, R.: The importance of endophenotypes
in studies of the genetics of schizophrenia. In, (K.L. Davis, D. Charney, J.T.
Coyle, C. Nemeroff, eds), Neuropsychopharmacology:
The Fifth Generation of Progress. Lippincott, Williams & Wilkins, Baltimore,
MD, pp. 703-716, 2002.
Paulus, M.P., Hozack, N.E., Zauscher, B.E., Frank, L.,
Brown, G.G., Braff, D.L., Schuckit, M.A.: Behavioral and functional
neuroimaging evidence for prefrontal
dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology,
26:53-63, 2002.
Cadenhead, K.S., Light, G.A., Geyer, M.A., McDowell, J.E., and
Braff, D.L.: Neurobiological measures in schizotypal personality
disorder: Defining an inhibitory
endophenotype? American Journal of Psychiatry, 159:869-871, 2002.
Perry, W.,
Feifel, D., Minassian, A., Bhattacharje, I., Braff, D.L.:
Information processing deficits in acutely psychotic schizophrenia patients
medicated and
unmedicated at the time of admission. American Journal of Psychiatry,159:1375-1381,
2002.
Paulus, M.P., Hozack, N.E., Zauscher, B.E., Frank, L., Brown, G.G., McDowell,
J., Braff, D.L.: Parietal dysfunction is associated with increased
outcome-related decision making in schizophrenia patients. Biological Psychiatry,
51:995-1004,
2002.
Paulus, M.P. & Braff, D.L.: Chaos and schizophrenia: Does the method
fit the madness? Biological Psychiatry, 53:3-11, 2003.
Ellwanger, J., Geyer,
M.A., Braff, D.L.: The relationship of age to prepulse inhibition and habituation
of the acoustic startle response. Biological Psychology,
62:175-195, 2003.
Green, M.F., Mintz, J., Salveson, D., Nuechterlein, K.H., Breitmeyer, B.,
Light, G.A., Braff, D.L.: Visual masking as a probe for abnormal
gamma range activity in schizophrenia. Biological Psychiatry, 53:1113-1119,
2003.
Lohr, J.B., Braff, D.L.: The value of referring to recently introduced
antipsychotics
as “second generation”. American Journal of Psychiatry, I160:1371-1372,
2003.
Schuckit, M.A., Kelsoe, J.R., Braff, D.L., Wilhelmsen, K.C.: Some possible
genetic parallels across alcoholism, bipolar disorder and schizophrenia. Journal
of Studies on Alcohol, 64:157-159, 2003.
Light, G.A., Braff. D.L.: Sensory gating deficits in schizophrenia: can we
parse the effects of medication, nicotine use, and changes in clinical status?
Clinical Neuroscience Research, 3:47-54, 2003.
Paulus, M.P. & Braff, D.L.: Chaos and schizophrenia: Does the method fit
the madness?: Reply. Biological Psychiatry, 54: 661, 2003.
Perry, W., Minassian, A., Cadenhead, K., Sprock, J., Braff, D.: The use of
the Ego Impairment Index across the schizophrenia spectrum. Journal of Personality
Assessment, 80:50-57, 2003.
Meincke, U., Light, G.A., Geyer, M.A., Braff, D.L., Gouzoulis-Mayfrank, E.:
Sensitization and habituation of the acoustic startle reflex in patients with
schizophrenia. Psychiatry Research, 126:51-61, 2004.
Braff, D.L. & Light, G.A.: Preattentional and attentional cognitive deficits
as targets for treating schizophrenia. Psychopharmacology, 174:75-85, 2004.
Light, G.A. & Braff, D.L.: Mismatch negativity deficits are associated
with poor functioning in schizophrenia patients. Archives of General Psychiatry,
62: 127-136, 2005.
Braff, D.L., Light, G.A., Ellwanger, J.W., Sprock, J., Swerdlow, N.R.: Female
schizophrenia patients have prepulse inhibition deficits. Biological Psychiatry,
57(7): 817-820, 2005.
Swerdlow NR, Stephany NL, Talledo J, Light G, Braff DL, Baeyens D, Auerbach
PP.: Prepulse inhibition of perceived stimulus intensity: paradigm assessment.
Biological Psychiatry, 69(2): 133-147, 2005
Swerdlow NR, Talledo JA, Braff DL: Startle modulation in Caucasian-Americans
and Asian-Americans: a prelude to genetic/endophenotypic studies across the
'Pacific Rim'. Psychiatric Genetics. 15(1):61-65, 2005
|
